A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia

NCT02057302 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2400

Enrollment

OTHER

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: Xuezhikang capsule

Sponsor

China Academy of Chinese Medical Sciences